NCT00439595

Brief Summary

A high proportion of children under the age of 5 years and pregnant women in Tanzania is anaemic, particularly in areas of high malaria transmission. The symptoms of anaemia are often non-specific or absent and clinical judgement is generally insensitive in estimating Hb levels, especially in infants who are assessed by basic grade health staff. Thus while treatment for the common causes of anaemia is available, many cases are not treated due to difficulties in recognising anaemia. New diagnostic tools can increase the sensitivity of anaemia detection compared to clinical diagnosis but no studies have demonstrated their effectiveness in increasing case-detection and treatment of anaemic patients at the first level of healthcare. In addition, the costs of their use in relation to any increase in numbers of cases treated are not known and this knowledge is needed to guide public health decisions. Two methods of measuring anaemia are currently suitable for use at the first level of care; Copack Haemoglobin colour scale (HBCS) and Hemocue portable photometry. We propose to compare the effectiveness in basic health facilities of these 2 simple diagnostic tools compared to control dispensaries (current practice) in increasing rates of detection and treatment of anaemia in children under the age of 5 years and pregnant women over the course of 1 year in a cluster-randomised trial in 30 dispensaries in a malaria-endemic area of NE Tanzania.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

February 22, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 23, 2007

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2008

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

May 27, 2010

Status Verified

May 1, 2010

Enrollment Period

1.2 years

First QC Date

February 22, 2007

Last Update Submit

May 26, 2010

Conditions

Keywords

AnaemiaDiagnosisPrimaryCareTreatment

Outcome Measures

Primary Outcomes (1)

  • The proportion of clinic attenders under the age of 5 years who are diagnosed with anaemia (adjusted for anaemia in the community)

    1 year

Secondary Outcomes (6)

  • Proportion of anaemic children and pregnant women treated for anaemia

    1 year

  • Prevalence of anaemia in study communities by age and season

    1 year

  • Proportion of clinic attenders referred to the district hospital with Hb> and <8g/dl.

    1 year

  • Effectiveness of current MOH anaemia treatment regimens.

    1 year

  • Acceptability of HBCS and Hemocue and attitudes to anaemia diagnosis among caretakers and healthworkers

    1 year

  • +1 more secondary outcomes

Study Arms (3)

1

EXPERIMENTAL

Hemocue 210 meter

Device: Hemocue 210 meter

2

EXPERIMENTAL

Copack HBCS

Device: Copack HBCS

3

NO INTERVENTION

Control

Interventions

Diagnostic device

1

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age under 5 years
  • Pregnancy
  • Suspected anaemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Handeni District Health Facilities

Tanga, Tanga, Tanzania

Location

MeSH Terms

Conditions

AnemiaDisease

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hugh Reyburn, MD

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 22, 2007

First Posted

February 23, 2007

Study Start

February 1, 2007

Primary Completion

April 1, 2008

Study Completion

May 1, 2008

Last Updated

May 27, 2010

Record last verified: 2010-05

Locations